Antimalarials are a medically important class of drugs that are used to combat malaria, a mosquito-borne infectious disorder and a leading cause of death in many tropical countries. They are also used in the prevention and treatment of certain forms of rheumatic diseases, such as lupus and rheumatoid arthritis. Antimalarials have been known to reduce the risk of developing severe malaria and to reduce the duration and severity of malaria symptoms when taken in accordance with medical advice. They can also be used to protect people living in or travelling to areas with a high risk of malaria. Antimalarials are effective and safe when used as directed by a medical professional, and in recent years the development of new antimalarials has improved the prognosis of malaria-affected populations.

From: International Journal of Anesthesia

Related Article For "Antimalarials"

About (1) results

Editor: Vipin Arora,  Department of Anesthesia, Critical Care and Pain Medicine, Harvard Medical School & Massachusetts General Hospital                                     
Publication Type: Open Access Journal
Description: International Journal of Anesthesia covers a wide selection of areas relevant to scientific and clinical content of anesthesiology field. IJAN aims to add real international flavor to anesthetic studies pertaining to all possible forms and to advance the understanding and application of novel techniques.